Yin Yongjia, Shen Cheng, Xie Pan, Cheng Zeneng, Zhu Qubo
The School of Pharmaceutical Science in Central South University, Changsha 410013, Hunan, China.
Breast. 2016 Apr;26:1-10. doi: 10.1016/j.breast.2015.11.008. Epub 2015 Dec 24.
microRNAs (miRNA) are involved in many biological processes. They repress target gene expression and play a vital role in breast invasive carcinoma (BRCA). Although many miRNAs are identified to be aberrantly expressed in BRCA and deemed as tumor markers, only sporadic individual studies report their target genes and the pathways involved.
miRNA and mRNA expression data were collected from the Cancer Genome Atlas (TCGA) pilot project. Aberrantly expressed miRNAs and mRNAs in BRCA were identified by comparing tumor samples with normal adjacent tissues. Differentially expressed miRNAs and mRNAs in different breast cancer subtypes were also analyzed. miRNA/target correlations were predicted by calculating the spearman correlation coefficients between miRNA and mRNA, and validated by luciferase assay.
31 up-regulated miRNAs, 37 down-regulated miRNAs, 1105 up-regulated mRNAs and 1222 down-regulated mRNAs were identified in BRCA; 125 miRNA/target correlations were predicted, 6 of them were validated. In addition, we also found 9 miRNAs and 143 mRNAs differently expressed between estrogen receptor positive and negative breast cancers, and 4 miRNAs and 46 mRNAs differently expressed between progesterone receptor positive and negative breast cancers. Twelve miRNA/target correlations determined the breast cancer subtypes.
We developed a new systematic analytic method for analyzing TCGA database, which took into account both miRNA and mRNA data to dissect the miRNA regulation network in BRCA.
微小RNA(miRNA)参与许多生物学过程。它们抑制靶基因表达,在乳腺浸润性癌(BRCA)中发挥至关重要的作用。尽管许多miRNA被鉴定为在BRCA中异常表达并被视为肿瘤标志物,但只有零星的个别研究报道了它们的靶基因及相关通路。
从癌症基因组图谱(TCGA)试点项目收集miRNA和mRNA表达数据。通过将肿瘤样本与相邻正常组织进行比较,鉴定出BRCA中异常表达的miRNA和mRNA。还分析了不同乳腺癌亚型中差异表达的miRNA和mRNA。通过计算miRNA与mRNA之间的斯皮尔曼相关系数预测miRNA/靶标相关性,并通过荧光素酶测定进行验证。
在BRCA中鉴定出31个上调的miRNA、37个下调的miRNA、1105个上调的mRNA和1222个下调的mRNA;预测了125个miRNA/靶标相关性,其中6个得到验证。此外,我们还发现雌激素受体阳性和阴性乳腺癌之间有9个miRNA和143个mRNA差异表达,孕激素受体阳性和阴性乳腺癌之间有4个miRNA和46个mRNA差异表达。12个miRNA/靶标相关性决定了乳腺癌亚型。
我们开发了一种新的系统分析方法来分析TCGA数据库,该方法同时考虑了miRNA和mRNA数据,以剖析BRCA中的miRNA调控网络。